Interestingly, the expression the mRNA for ANP, a marker for cardiac hypertrophy, that was noted to be elevated in PP2A-TG controls, as expected in a mouse model with cardiac hypertrophy [11], decreased to WT levels after LPS (Figure 5B). This evidence concerns the gene PTPA and cardiac hypertrophy.